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RESEARCH ABSTRACT
The specification of Primordial Germ Cells (PGCs) in early mammalian development is a fundamental
process of development, critical for, maintaining the germ line. There are two methods by which
PGCs are specified in the animal kingdom. Firstly, through the predetermined method involving
maternally inherited germplasm, and secondly through the induction of pluripotent precursors in a
process termed epigenesis. Embryoid Bodies (EBs) can be used to recapitulate early developmental
processes of mammalian development, allowing the dissection and better understanding of critical
processes. This project will aim to try and better understand the role of the homeobox transcription
factor Nanog in specifying PGCs through the process of epigenesis. Mouse Nanog over-expression in
EBs has been shown to increase PGC specification, assayed through RT-PCR analysis. The
functional activity of ancestral Nanog is hypothesised to be conserved through the major trunk of
evolution in organisms that specify PGCs through the induced method of epigenesis. To test this
hypothesis, ancient Nanog orthologs were isolated from different positions of the Deuterostome
superfamily and over-expressed in EBs. Their effects on enhancing PGC specification were then
quantified through quantitative RT-PCR and western blot analysis. The results from this project show
that the over-expression of ancient Nanog orthologs in mES cells can enhance the process of PGC
specification, by increasing the PGC associated markers Dazl and Vasa. This suggests a possible
conservation of functional Nanog activity in organisms that specify PGCs through epigenesis, and
also that pluripotency is an ancient trait.
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RESEARCH ABSTRACT 
 
 
The specification of Primordial Germ Cells (PGCs) in early mammalian development is 
a fundamental process of development, critical for, maintaining the germ line. There 
are two methods by which PGCs are specified in the animal kingdom. Firstly, through 
the predetermined method involving maternally inherited germplasm, and secondly 
through the induction of pluripotent precursors in a process termed epigenesis. 
Embryoid Bodies (EBs) can be used to recapitulate early developmental processes of 
mammalian development, allowing the dissection and better understanding of critical 
processes. This project will aim to try and better understand the role of the homeobox 
transcription factor Nanog in specifying PGCs through the process of epigenesis. 
Mouse Nanog over-expression in EBs has been shown to increase PGC specification, 
assayed through RT-PCR analysis. The functional activity of ancestral Nanog is 
hypothesised to be conserved through the major trunk of evolution in organisms that 
specify PGCs through the induced method of epigenesis. To test this hypothesis, 
ancient Nanog orthologs were isolated from different positions of the Deuterostome 
superfamily and over-expressed in EBs. Their effects on enhancing PGC specification 
were then quantified through quantitative RT-PCR and western blot analysis. The 
results from this project show that the over-expression of ancient Nanog orthologs in 
mES cells can enhance the process of PGC specification, by increasing the PGC 
associated markers Dazl and Vasa. This suggests a possible conservation of 
functional Nanog activity in organisms that specify PGCs through epigenesis, and also 
that pluripotency is an ancient trait.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Pluripotency  
 
$VWHPFHOO¶V³SRWHQF\´FDQEHGHILQHGDVLWVSRWHQWLDOWRGLIIHUHQWLDWHDQGSURGXFHFHOO
W\SHV IURPGLIIHUHQW OLQHDJHV$VGLIIHUHQWLDWLRQSURFHHGVGRZQD³RQH-ZD\VWUHHW´D
VWHPFHOO¶VSRWHQF\LVGLPLQished, becoming increasingly more restricted by epigenetic 
events, which include the repression of pluripotency associated genes (Kim. J et al., 
2008). Repression of pluripotency genes is coupled with the activation of cell lineage 
specific genes. The ordering of stem cells according to their potency is seen to be 
ordered in a hierarchical structure.  
 
In mammals, the ability of a cell to produce all the cell types required to build an 
organism, including the extra-embryonic tissue, is termed ³WRWLSRWHQW´ 7KHVH
unrestricted cells have been identified in the early embryo at the 4-cell (Morula) stage. 
As differentiation proceeds, the ability to produce extra-embryonic tissue is lost but the 
multi-lineage potential to form cells of all three embryonic germ layers is retained. This 
ability to produce all cell types of both the embryo and associated germline is termed 
³SOXULSRWHQW´ 3OXULSRWHQW FHOOV DUH IRXQG LQ D VXEVHW RI FHOOV LQ WKH Geveloping 
mammalian blastula (Figure. 1). 
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Figure 1: Hierarchy of stem cell potential. Stem cells can be characterised in a 
hierarchical structure with the mRVW³SRWHQW´FHOOVEHLQJDWWKH³top of the tree´. As differentiation 
proceeds, cells become more restricted and cell potency is diminished. Pluripotent cells have 
the potential to produce cells from all the three germ layers: the endoderm, mesoderm and 
ectoderm. They are however not able to produce extra-embryonic tissue, such as the placenta.  
 
1.2 Embryonic Stem Cells 
 
In the 1960s, a germ cell cancer cell line isolated from a teratocarcinoma (germ cell 
tumour) was found to display close similarity to the cells of the Inner Cell Mass (ICM) 
of a developing mouse. These cancer germ cells were successfully grown in culture 
as cancer stem cells.  
 
Being derived from a cancer cell line, however, meant that the cancer germline stem 
cells harboured genetic abnormalities. Despite this, they were initially used to model 
early mouse development. This work identified the need to isolate the unrestricted 
potential of cells in the ICM of developing mouse embryos. In the early 1980s, cells of 
the ICM ZHUHFDSWXUHG LQFXOWXUHDQG WHUPHG³0RXVH(PEU\RQLF6WHP&HOOV´ PES 
cells)  (Martin. G. R, 1980), (Evans. M. J and Kaufman. M. H, 1981) (Figure. 3A).  
 
Developing Fetus 
Morula 4-Cell Stage Blastula 
Inner Cell Mass 
Adult Stem Cell 
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In 1998, Human Embryonic Stem Cells (hES cells) were successfully isolated and 
cultured in defined media on fibroblast cell feeder layers (Thomson. J. A et al., 1998) 
(Figure. 3B).  
 
ES cells are GHILQHGDVEHLQJ³SOXULSRWHQW´SRVVHVVLQJWKHDELOLW\WRERWK 
 
1. self-renew indefinitely in an undifferentiated state 
2. differentiate down different cellular lineages; producing adult cell types from all 
three germ layers, that is, ectoderm, mesoderm and endoderm, as well as germ 
cells 
 
The possession of these two defining properties is what makes ES cells of great 
importance and use.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Potential of pluripotent ES cells to divide and self-renew. ES cells 
possess the ability to derive different cellular lineages of the three germ cell layers, whilst 
retaining the ability to self-renew.  
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The ability of ES cells to both self-renew and to differentiate down cellular lineages 
means that ES cells are distinct from more differentiated and restricted types of adult 
multi-potent stem cells, for example Neuronal Stem Cells (NSCs) (Figure 2).  
Undifferentiated ES cells can be cultured in defined media for unrestricted periods of 
WLPH PDNLQJ WKHP ³LPPRUWDO´ &XOWXULQJ (6 FHOOV in vitro arrests the normal 
developmental process seen in vivo. This makes the isolation and culture of ES cells 
distinct from the culture of whole animal embryos, which do not arrest when isolated 
and continue to progress forward with development. The ability to culture large 
populations of undifferentiated ES cells has made them an attractive target for a 
number of applications. Before the full potential of ES cells can be fully harnessed, 
control mechanisms and underlying cellular regulation need to be characterised.  
 
In mES culture, media is supplemented with the cytokine Leukaemia Inhibitory Factor 
(LIF) and Bone Morphogenic Proteins (BMPs), allowing cells to remain in an 
undifferentiated state in cell culture flasks (Ying. Q. L et al., 2003), (Smith. A. G et al., 
1988). In hES cell culture, FGF and activin are required along with fibroblast feeder 
cell layers (Vallier. L et al., 2005). LIF has been shown to drive ES cell self-renewal by 
activating the transcription factor STAT3 (Ying. Q. L et al., 2003), involved in 
downstream target gene expression. However, LIF alone has been shown to be 
insufficient to maintain self-renewal and is dependent on interplay with BMPs to 
preserve the multi-lineage potential and other associated ES cell properties (Ying. Q. 
L et al., 2003). The need for BMPs in culturing ES cells resides within the activation of 
the Id genes, a member of the basic helix-loop-helix (bHLH) family, via the Smad 
pathway (Hollnagel. A et al., 1999).  
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Figure 3: ES cell culture in vitro. (A) In vitro cultured mES cells  (B) cultured hES cells on 
fibroblast feeder cell layers (Miller. J, 2006) 
 
Assaying for undifferentiated ES cells can be achieved by using Alkaline Phosphotase 
(AP) staining, which can be used as a measure of ES cell self-renewal. A high level of 
AP is a characteristic marker of undifferentiated ES cells and is therefore a useful tool 
in identifying specific pluripotent colonies. As differentiation of ES cells proceeds, AP 
levels decrease. 
 
Another assay that is used for the characterisation of ES cells exploits their unique 
ability to form non-FDQFHURXV WXPRXUV WHUPHG ³WHUDWRPDV´ 7HUDWRPDV DUH WXPRXUV
that are formed from tissues or organs from all three germ layers (Baker. M, 2009). As 
the ability to produce all cell types of the three germ layers is characteristic of ES cells, 
teratoma formation serves as a valuable diagnostic tool to study differentiation.  
 
1.3 Nanog 
 
Nanog is a member of the homeobox transcription factor family Homeobox factors 
play an important role in the control of development. The study of Nanog allows the 
opportunity to uncover and dissect the control mechanisms underlying the 
maintenance of pluripotency in ES cells, in which Nanog has been shown to be a key 
player (Silva. J et al., 2009). Nanog and its role in pluripotency were discovered 
independently by two separate research groups.  
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One used in silico subtraction studies (Mitsui. K et al., 2003b) which identified Nanog 
as a potential ES cell associated transcription factor. Further work in the form of gene 
deletion studies then showed that Nanog was required to maintain epiblast identity, 
whilst also being involved in the regulation of pluripotency.  
 
Parallel studies identified 1DQRJ¶s role in pluripotency by selecting cDNA from an ES 
cell cDNA library, followed by testing for specific cDNAs which allowed the process of 
self-renewal to occur in the absence of LIF (Chambers. I et al., 2003a). This showed 
Nanog to be a pluripotency associated transcription factor, involved with enhancing 
the process of self-UHQHZDO RI XQGLIIHUHQWLDWHG (6 FHOOV PDNLQJ WKHP ³LPPRUWDO´
(Mitsui. K et al., 2003a), (Chambers. I et al., 2003b). Nanog over-expression is 
characterised by its ability to maintain ES cells in the absence of cytokines, such as, 
LIF (Yates. A and Chambers. I, 2005). Further to the control of ES cells, Nanog has 
been found in pluripotent cells of embryos, as well as in derivative ES cells and in the 
developing germline of mammals (Chambers. I et al., 2003a). 
 
ES cell and NSC fusion experiments have shown that the developmental 
programming imposed on differentiated cells can be erased (Silva. J et al., 2006), 
(Wong. C. C et al., 2008). In stem cell fusion assays, Nanog promotes pluripotent 
gene activation; meaning that pluripotency is a phenotypically dominant trait conferred 
to the somatic cell nucleus through the action of Nanog (Silva. J et al., 2006).  It has 
also been noted that Nanog deletion in early embryo development is characterised as 
being lethal; the embryo is arrested in development prior to implantation (Chambers. I 
et al., 2007), (Mitsui. K et al., 2003b).   
 
In 2006, it was shown that fully differentiated mouse skin fibroblasts could be reversed 
to achieve the pluripotent characteristics reminiscent of ES cells. The production of 
reprogrammed Induced Pluripotent Stem (iPS) cells demonstrates the importance that 
Nanog plays in ES cells.  
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The first mouse iPS cells produced were reprogrammed with four core factors; Oct-4, 
Sox-2, Klf4 and c-myc (Takahashi. K and Yamanaka. S, 2006).The four core 
transcription factors were introduced to differentiated fibroblast cells by an engineered 
retrovirus. After a period of culturing the cells, pluripotency assays confirmed the 
reprogrammed state of the iPS cells. This work was then extended a year later to 
produce reprogrammed human iPS cells from differentiated human fibroblasts 
(Takahashi. K et al., 2007). Surprisingly, Nanog was not required as an exogenous 
factor in the early reprogramming steps  of producing iPS cells (Okita. K et al., 2007), 
(Takahashi. K et al., 2007). It is also noteworthy that the addition of Nanog to the four 
core factors has not been shown to increase the efficiency of iPS cell reprogramming. 
 
Although Nanog was not one of the four core factors used in early reprogramming, the 
switch from differentiated cell to iPS cell is achieved by the activation of the resident 
Nanog gene. For this reason, Nanog KDV EHHQ WHUPHG WKH ³JDWHNHHSHU RI
SOXULSRWHQF\´ZKRVHIXQFWLRQLVUHTXLUHGWRDFKLHYHJURXQGVWDWHSOXULSRWHQF\(Silva. J 
et al., 2009). Screening for Nanog activation in early reprogrammed cells enables 
selection for fully reprogrammed iPS cells (Okita. K et al., 2007). These Nanog-
selected iPS cells can contribute to adult chimeras and also possess the ability to 
contribute to the germline, a hallmark of pluripotency. Without Nanog activation, 
partially reprogrammed cells would remain in an intermediate non-viable and non-
pluripotent state. 
 
Nanog expression is required to produce both germ cells, which transmit heritable 
characteristics to offspring, and other non-VH[ FHOOV WHUPHG ³VRPDWLF FHOOV´ VRPD
which comprise the organs of adults. Nanog has been shown to be highly expressed 
in PGCs of mouse embryos at Embryonic day (E) 11.5 and E12.5 (Yamaguchi. S et 
al., 2005), at a time in which there are dramatic epigenetic changes (Chambers. I et 
al., 2007). The role of Nanog in germ cell development is demonstrated by the fact 
that germ cells do not develop past stage E11.5 in the absence of Nanog (Chambers. 
I et al., 2007), suggesting a role in germ cell maturation.  
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Genital ridges of Nanog-null subject mice were dissected and stained for pluripotency 
associated factors, such as, Oct-4 as well as MvhI, a mouse VASA homolog and a 
marker of mature germ cells. The results showed co-localisation of pluripotency 
associated factors and germ cell specific markers in wild-type mice, but PGCs derived 
from Nanog null ES cells could not mature to the stage of Vasa expression. To 
support the evidence that Nanog is required in germ cell maturation, homologous 
recombination of one Nanog allele was shown to restore functionality and 
consequently germ cell maturation (Chambers. I et al., 2007).   
 
It has been suggested (Silva et al. 2008) that temporary absence of Nanog in ES cells 
does not affect their self-renewal capacity, however, a predisposition to differentiation 
is increased (Figure. 4). It was found that transient Nanog expression in ES cells 
RSHQHG D ³ZLQGRZ RI RSSRUWXQLW\´ in which differentiation increased, however, not 
forcing ES cells to do so. The same study showed that undifferentiated ES cells may 
lose Nanog expression and then subsequently reacquire it. Also, Nanog-null ES cells 
were able to contribute to various cellular lineages, including liver, neuronal, heart 
muscle and kidney. These results show that multi-lineage potential is not lost in the 
absence of Nanog however a lack of mature PGCs is observed.  
 
 
 
 
 
 
 
Figure 4: Nanog expression can be lost and subsequently reacquired. A model to 
show that Nanog expression may be lost in undifferentiated ES cells and then subsequently 
UHJDLQHG $ ³ZLQGRZ RI RSSRUWXQLW\´ LV VHHQ GXULQJ WUDQVLHQW Nanog expression in which cell 
differentiation is seen to occur at increased levels (Adapted from (Chambers. I et al., 2007)) 
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1.4 Forms of Nanog 
 
The Nanog gene is conserved in evolution. Nanog homologs have been identified at 
the same positions on the chromosomes of chimpanzees (Fairbanks. D. J and 
Maughan. P. J, 2006) and amongst other species, such as  chicken (Lavial. F et al., 
2007), zebrafish (Camp. E et al., 2009), mouse (Mitsui. K et al., 2003a). It is thought 
that the origins of the human NANOG gene predate the branching of the human 
species, back through evolution.  
 
Nanog can exist in two forms, firstly as a monomer in species such as axolotl and also 
in the form of a dimer in mammals. The cause of this variation lies in the tryptophan 
repeat (WR) domain, present at the C-terminal domain (Wang et al., 2008), which is 
present in the mammalian dimer form of Nanog, but not in the Nanog monomer form. 
The WR repeat domain is responsible for driving the dimerisation of Nanog. Studies 
have shown that the dimer form of Nanog found in mammals regulates ES cell 
proliferation (Ma. T et al., 2009). However, the repression of ES cell differentiation can 
be achieved by the monomeric ancestral form of Nanog (Dixon. J. E et al., 2010). It 
has been suggested that the tryptophan WR repeat domain found in the Nanog dimer 
evolved from the ancestral monomer to allow epiblast expansion in mammals.  
 
1.5 Other Pluripotency Associated Factors 
 
A critical factor associated along with Nanog in the maintenance of pluripotency in ES 
cells is the homeobox transcription factor  Oct-4, also known as POU5F1 (Niwa. H et 
al., 2000) (van den Berg et al., 2010). In Oct-4 gene knockdown experiments 
differentiation is observed, demonstrating its critical role in ES self-renewal (Hough. S. 
R et al., 2006). As a result, Oct-4 expression is used as a marker of pluripotent cells. 
In mammalian development, Oct-4 is expressed strongly in all of the cells in the ICM, 
as opposed to Nanog which is confined to a subset of these cells (Silva. J et al., 
2009).   
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In undifferentiated ES cells, ChIP analysis has shown that the Oct-3/4 histones are 
highly acetylated, i.e. strongly expressed but as differentiation proceeds, the promoter 
is slowly deacetylated (Feldman. N et al., 2006). Work by (Liang. J et al., 2008) has 
shown that Nanog and Oct-4 interact, communicating with distant repression 
complexes to regulate gene transcription. The repression complex GCNF has been 
shown to play a role in the repression of Oct-4 in somatic cells during the process of 
early embryonic development (Gu. P et al., 2005).     
 
Cdx2 is also a key homeobox transcription factor. It is involved in the development of 
the placenta during embryogenesis (Niwa. H et al., 2005). Trophectoderm is the first 
cell lineage that develops during mammalian embryo development, due to the 
repression of pluripotency associated genes. Cdx2 and the pluripotency associated 
transcription factor Oct-4, have been shown to be reciprocal inhibitors (Kuckenberg. P 
et al., 2010). This leads to the possibility that the first differentiation event  in 
mammalian development is under the control of Cdx2 and Oct-4 (Niwa. H et al., 2005)  
(Figure. 5).    
 
 
Figure 5: Transcriptional regulation of ES cells. Nanog and Oct-4 transcription factor 
expression are involved in the maintenance of pluripotency in ES cells. Over expression of 
Nanog has been shown to cause the reversion to a primitive ectodermal form (red dashed 
arrowed line). Gata6 acts as a Nanog antagonist in forcing differentiation of extra embryonic 
lineages (Niwa. H et al., 2005). [Reproduced from Cell, Volume 123, Issue 5, 2nd December 
 ³,QWHUDFWLRQ EHWZHHQ 2FW DQG &G[ 'HWHUPLQHV 7URSKHFWRGHUP 'LIIHUHQWLDWLRQ´ ZLWK
permission from Elsevier] 
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1.6 Pluripotency Networks 
 
During germline development, there is seen to be dramatic epigenetic erasure, unique 
PGCs, followed by the re-establishment of epigenetic modifications (Allegrucci. C et 
al., 2005). As germ cells mediate germline transmission, they are considered to be 
³LPPRUWDO´ DV WKH\ DUH WKH OLQN EHWZHHQ JHQHUDWLRQV (Figure. 6). In an evolutionary 
sense, the purpose of the somatic cells (soma) is to facilitate the passing on of this 
heritable information from one generation to the next.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Continuation of the germline. Germ Cells are involved in passing on heritable 
information from generation to generation and the continuation of the germline. Somatic cells 
exist evolutionary to support and facilitate transfer of this heritable information to offspring and 
die off at each generation 
 
In terms of germ cell specification during early development, it is possible to split the 
Animal Kingdom into two distinct groups (Bachvarova. R. F et al., 2004). There are 
two ways in which Primordial Germ Cells (PGCs), the precursors to mature haploid 
gametes (sex cells), can be established during early development (Johnson. A. D et 
al., 2003b): 
 
 
 
 
Germ Cell 
Generation 1 
Germ Cell 
Generation 2 
Germ Cell 
Generation 3 
Continuation of the germline 
Somatic cells die off 
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1. Specification through germplasm (Predetermined Method) 
 
One way to specify PGCs is through the action of germplasm, as initially proposed by 
August Weismann. Maternally inherited germplasm functions by inhibiting extracellular 
signals and restricting differentiation of a subset of cells during development, which go 
on to turn germline (Houston. D. W and King. M. L, 2000). The evolution of germplasm 
has been shown to have occurred several times in different species independently 
(Johnson. A. D et al., 2003b, Johnson. A. D et al., 2003a). As germplasm evolved as a 
means to specify PGCs, it is hypothesised there was a loss of need, and consequent 
deletion, of the Nanog gene in frogs (Dixon et al., 2010).  This idea has been 
proposed as a reason for the lack of a Nanog gene in organisms that specify PGCs 
through the predetermined method, utilising germplasm.  
 
7KH ³:HLVPDQQ %DUULHU´ LV D WHUP WKDW LV XVHG WR UHIHU WR WKH UHVWULFWHG RQH-way 
transmission of genetic information from the germ cells to the soma; genetic 
information cannot travel in the opposite direction. This system of germ cell formation 
is present in species such as the amphibian Xenopus laevis, the fruit fly Drosophila 
melanogaster, the nematode C. elegans, to name just a few. 
 
2. Specification through Epigenesis (Induced Method) 
 
The second way of specifying germ cells during development is through the process of 
epigenesis. This is achieved by the induction of pluripotent precursors (Extavour. C. G 
and Akam. M, 2003) and is thought to involve the action of the Nanog transcription 
factor. This system is utilised by chordates and amniotes, including salamanders and 
mammals, and has been proposed to be conserved through the trunk of chordate 
evolution (Johnson. A. D et al., 2003a).    
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In mammals PGCs are induced early in gastrulation, that is, the process that initiates 
the formation of the three embryonic germ layers.  PGCs are internalised along with 
the future extra-embryonic mesoderm in the early posterior primitive streak, followed 
by specification (Bachvarova et al., 2009). There exists strong evidence that a process 
of inductive germ cell specification, similar to that in mammals, also occurs in turtles 
and some other reptiles (Bachvarova et al., 2009).  
 
During the development of amniotes, it has been shown that the PGCs appear before 
the formation of the gonad in the posterior trunk; their final destination. This results in 
a period of time in which the PGCs are located outside the gonads, requiring migration 
and colonisation of the gonad (Bachvarova et al., 2009). In contrast, in urodeles the 
PGCs appear relatively late (Bachvarova. R. F et al., 2004), and throughout 
development maintain a position close to precursors of the somatic cells of the gonad 
so that migration is not required (Bachvarova et al., 2009). In lampreys, early 
development of germ cells is highly similar to that of urodeles, suggesting this is the 
primitive vertebrate process.  
 
Amphibians diverged around two hundred and fifty million years ago producing two 
distinct lineages, urodeles, such as the axolotl and anurans, such as xenopus.  
Urodeles have more traits conserved with mammals than do anurans; one example is 
the conservation of Nanog in urodeles and mammals. (Nieuwkoop. P. D, 1969) 
showed the differences between anurans and urodele embryos. He noted that 
mesoderm formation was different between the two lineages: anurans have a double-
layered blastula compared to the single-layer seen in urodeles. There is also a 
different method of germ cell specification: anurans inherit maternal germplasm whilst 
uURGHOHV KDYH DQ LQGXFHG PHFKDQLVP RI 3*& IRUPDWLRQ 1LHXZNRRS¶V FODVVLF
experiments demonstrated the ability of axolotl animal caps to produce PGCs when 
exposed to inducing signals from the mesoderm. The same PGC induction cannot be 
achieved for Xenopus embryos, suggesting that the mechanism of PGC specification 
is conserved from urodeles to mammals (Johnson et al., 2003). 
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Nanog germplasm 
Urodeles  + - 
Acorn Worm + - 
Mouse + - 
Amphioxus + - 
Sturgeon + - 
Zebrafish - + 
Birds - + 
Anurans  - + 
Drosophila - + 
 
Figure 7: Methods of specifying PGCs.  A table to show a selection of species and the 
vDULDWLRQ LQ3*&VSHFLILFDWLRQGXULQJHDUO\GHYHORSPHQW$³´ LQ WKH Nanog column indicates 
that particular species group utilises Nanog and the process of epigenesis to specify PGCs and 
$³´LQWKHgermplasm FROXPQLQGLFDWHVWKDWSDUWLFXODUVSHFLHVGRHVQ¶WKDYHDNanog gene 
 
  
1.7 Germ Cell Production In Vitro 
 
In vitro, it is possible to derive PGCs through Embryoid Body (EB) intermediates 
(Toyooka. Y et al., 2003). EBs can be created from the aggregation of mES cells in a 
³KDQJLQJGURS´ ZKLFKFDXVHVP(6FHOOV WR FOXVWHU (%VFDQ WKHQ be collected from 
hanging drops and cultured in vitro, where they differentiate spontaneously. EBs serve 
as a powerful tool as they mimic many early developmental processes of mammalian 
development. However, as ES cells are pluripotent and have multi-lineage potential, 
the EBs are composed of a wide variety of differentiated cell types, which form in a 
disorganised manner. This is in contrast to the tightly regulated processes involved in 
normal embryonic development. Despite this, EBs can be used to dissect early 
developmental processes. Specified PGCs can be isolated from differentiating EBs 
and embryonic germ cell lines.  
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George Daley and colleagues (Geijsen. N et al., 2004) showed that the methylation 
patterns of both the Igf2r and H19 genes were erased in the isolated embryonic germ 
cells, as is seen in the normal germ cell lineage.  
 
1.8 Germ Cell Specification Factors 
 
Dazl (deleted in azoospermia-like), a germ cell specific RNA binding protein, is a key 
regulator in early germ cell specification (Kee. K et al., 2009). The related genes DAZ 
and BOULE mediate germ cell development and progression to mature haploid 
gametes. The interplay between Dazl, DAZ and BOULE allows the development and 
maturation of PGCs to mature sperm and egg cells. Over-expression of Dazl was 
seen to suppress the activity of Nanog and induced germ cell nuclear antigen in mES 
cells (Kee. K et al., 2009). Dazl knockdown resulted in lower expression levels of the 
germ cell specific genes Stella, MvhI (mouse Vasa homolog) and Prdm1 (Blimp1).  
 
Blimp1 knock-out experiments have identified roles in germ cell specification during 
the process of early development (Ohinata et al., 2005). It was shown in the same 
study that Blimp1 functions as a transcriptional repressor by blocking extracellular 
signals, e.g. from cytokines, in much the same way as germplasm functions. This 
SUHYHQWVDVXEVHWRIFHOOVIURP³WXUQLQJVRPDWLF´VHWWLQJWKHgermline apart from other 
cell types. Consequently, Blimp1 null embryos lack PGC development (Ohinata et al., 
2005). The RNA binding protein Lin 28 has been identified as a key regulator of PGC 
formation during development (West. J. A et al., 2009).  RNA interference (RNAi) was 
used to screen candidate genes for effects of PGC development in Stella (also called 
Dppa3) expressing mES lines. Blimp1 has the ability to rescue PGCs in Lin 28-
deficient cells and therefore demonstrated its importance in PGC specification (West. 
J. A et al., 2009).   
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1.9 Developmental Constraint and Constraint Release 
 
PGC specification by germplasm is correlated with greater species variation within a 
lineage than is possible through the induced method of PGC specification. This is 
because germplasm allows germ cells to function independently of signals from the 
somD LH WKHVRPDWLF FHOOVGRQ¶W influence germ cells. This creates an environment 
where mutations and alterations to the somatic cells do not affect the transmission of 
heritable information through the germline. This is proposed as the reason for large 
variation and diversity seen in species that utilise the germplasm method of germ cell 
specification (Crother. B. I et al., 2007). It is more advantageous in terms of species 
diversity and variation to have a weak association between the germline and soma; 
this weak association is seen in germplasm specification of germ cells. Mammals and 
other organisms specifying germ cells through induction from pluripotent precursors 
have a much tighter connection between the germline and the soma. Any large 
mutations in the somatic cells has an influence on the germ cells and consequently 
the transmission of the heritable information through the germline (Crother. B. I et al., 
2007). A two-step process has been proposed for identifying constraints and 
constraint release processes in macroevolution (Crother. B. I et al., 2007). Constraints 
are associated with primitive traits whilst constraint release was linked to derived traits 
(this proposal can be applied to the case of PGC speciation where the primitive trait, 
i.e. Nanog, is a constraint and the derived germplasm trait is the release).  
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CHAPTER 2: WORKING HYPOTHESIS 
 
It has been proposed that the evolution of germplasm creates a permissive condition 
for the loss of Nanog. This has been proposed as a reason why Nanog was deleted 
from the frog genome (Dixon. J. E et al., 2010). The Nanog homeobox transcription 
factor is present in organisms that specify PGCs through epigenesis and proposed to 
be conserved through evolution. Mammals are thought to have evolved from a lineage 
of reptiles resembling the axolotl (salamander); as a result they are expected to share 
the same functional Nanog activity (Dixon. J. E et al., 2010).   
 
Unpublished work by Dixon et al. has shown that the over-expression of mouse Nanog 
in mES cells serves to increase the number of PGCs seen in EB differentiation 
experiments. These results lead onto the intriguing question of whether the ability of 
Nanog in increasing PGC specification has been conserved in ancient Nanog. If 
ancient Nanog over-expression in increasing the induction of PGCs has been 
conserved, it would show that in fact Nanog genes function in the process of PGC 
specification and subsequently has been conserved through the main trunk of 
evolution.  
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CHAPTER 3: AIMS OF RESEARCH 
 
Question: 
³,V WKH DELOLW\ RI PRXVH Nanog over-expression to increase PGC specification 
conserved in ancient Nanog orthologV"´ 
 
Mouse Nanog over expression in mES cells has been shown to increase the level of 
PGC induction in EBs compared to the induction level seen EBs formed from control 
cell lines (James Dixon and Andrew Johnson, unpublished). The purpose of my work 
was to test whether the increase in PGC specification caused by over-expression of 
Nanog is a conserved trait, i.e. can ancient Nanog orthologs also induce an increase 
in PGC specification in EBs. To test this hypothesis mES cell lines over-expressing 
ancient Nanog orthologs will be tested for PGC specification. 
 
Induction of PGCs will be measured firstly by quantitative RT-PCR for the germ cell 
markers Dazl and Vasa, whilst also monitoring the pluripotency and germline 
associated markers Nanog and Oct-4 DJDLQVW D PRXVH ȕ-Actin housekeeping gene 
control. Gene expression levels in the ancient Nanog over-expression EBs will be 
compared to the control levels found in cells containing an empty control vector. 
Western blotting will be used to confirm Vasa expression specifically.  
 
1. I produced pure populations of ancient Nanog ortholog over-expression mES lines 
utilising the pSIN vector and reaffirmed that mouse Nanog over-expression 
increased PGC specification (James Dixon and Andrew Johnson, unpublished) 
 
2. I produced EBs from ancient Nanog over expression mES lines and test for PGC 
induction compared with rates observed in control pSIN-Empty produced EBs 
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CHAPTER 4: MATERIALS AND METHODS 
 
4.1 Real Time PCR 
 
TaqMan REAL Time PCR (RT-PCR) was carried out on template cDNA to assay 
target gene expression. Individual target gene master mixes were made up in a 
controlled sterile hood and were constituted of: 
 
10ȝO7DT0DQ*HQH([SUHVVLRQ0DVWHU0L[ 
ȝO7DUJHW*HQH3ULPHU3UREH0L[ 
ȝO7HPSODWHF'1$ 
ȝO1XFOHDVH)UHHG+2 
 
Template cDNA was added to master mixes on RT-PCR mixing plates (Thermo 
6FLHQWLILF EHIRUH ȝO DOLTXRWV ZHUH WUDQVIHUUHG RQWR 57-PCR reading plates 
(Applied Biosystems). The RT-PCR reading plate were then sealed with optical 
adhesive film (Applied Biosystems), centrifuged to remove any air bubbles and to 
collect as the base of the tube followed by loading and analysis for forty cycles of 
amplification on an Applied Biosystems 7500 PCR System.. Triplicate assays 
were carried out for each sample to obtain an average expression level.  
 
4.2 Transformation 
 
Fifty microlitres of competent E. Coli 5-a cells (NEB) were thawed on ice and 
transferred into a sterile 1.5ml eppendorf tube.  1-ȝORISODVPLG'1$ ZDV WKHQ
added to the competent cells and mixed by pipetting before incubation on ice for 
30 minutes. The mixture was then heat shocked at 42϶C for 42 seconds in a pre-
heated water bath.   
per 2ȝO  individual RT-PCR reaction 
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Next, the mixture was snap FKLOOHGRQLFHIRUPLQXWHVȝORI62&PHGLDZDV
then added and mixed by pipetting, followed by incubation for one hour at 37϶C in 
a shaker incubator to amplify transformed competent cells. 
 
4.3 Ampicillin Plating of Transformed Competent Cells 
 
Three hundred millilitres of solid Mu agar (low salt concentration) was heated in a 
microwave until melted and left to cool. 2.5g of ampicillin sodium salt (SIGMA) 
was then dissolved in a 25ml 50:50 ratio consisting of 12.5ml distilled water and 
12.5ml of 100% ethanol to produce a working concentration.  To the cooled Mu 
agar the ampicillin salt working solution was added to produce a final 
FRQFHQWUDWLRQRIȝJPO7KH0X$JDUZDVWKHQSRXUHGLQWRVWHULOHSHWULGLVKHV
under flame and left to set overnight.  
 
Bacterial cultures were plated (usually 10-ȝOZLWKȝORIPJPO;-Gal, using 
a glass spreader that has been sterilised in ethanol. Incubation is at 37϶C for 16 
hours (overnight). X-Gal was used to screen for successfully transformed 
colonies. 
 
4.4. P-GEMT Easy Cloning 
 
The p-GEMT easy vector (Promega) was used to clone amplified PCR products 
with restriction enzyme sites on either end of the amplicon. Cloning of PCR 
amplified inserts into the pGEMT Easy vector along with control insert DNA was 
FDUULHGRXWDVSHUWKH3URPHJD¶VLQVWUXFWLRQV 
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Standard 
Reaction 
Control 
Reaction 
2X Rapid Ligation Buffer ȝO ȝO 
pGEM-T Easy Vector (50ng) ȝO ȝO 
PCR Insert ;ȝO - 
Control DNA Insert - ȝO 
T4 DNA Ligase ȝO ȝO 
Nuclease-)UHH:DWHUWRȝOTotal 
Volume ȝO ȝO 
 
 (Adapted from Promega pGEMT Easy Technical Manual) 
 
The ligation reaction was then carried out overnight at 16϶C to obtain the highest 
ligation efficiency. An EcoRI or NotI digest was then used to release the PCR 
amplicon from the p-GEMT easy vector. 
 
4.5 Plasmid DNA Extraction 
 
QIAprep Spin DNA extractions were carried out to isolate plasmid DNA from 
EDFWHULDOFXOWXUHV([WUDFWLRQZDVFDUULHGRXWSHU4LDJHQ¶V WHFKQLFDO LQVWUXFWLRQV
DNA adsorbed onto the spin column silica membrane and finally washing and 
elution DNA with wither Elution Buffer (Qiagen) or TE buffer (10mM Tris-HCl pH 
7.5; 0.05M EDTA) to prevent magnesium-dependant enzymatic cutting of 
extracted DNA. 
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4.6 RNA Extraction 
 
RNA extraction from mES cells and EBs was carried out firstly by using 
QIAshredder (Qiagen) to lyse cells and remove cell debris. An RNeasy kit 
(Qiagen) was then used on the lysate to adsorb RNA onto the spin column 
membrane before carrying out an in-column DNase treatment (Promega) to 
remove any contaminating DNA by incubating at 37϶C for one hour.   
 
4.7 Nanodrop Quantification of RNA and DNA 
 
Quantification of the DNA concentration was carried out by using the Nanodrop 
Spectrophotometer (ND-1000). For DNA quantification, the 260:280 ratio, an 
indication of sample purity, would be 1.8 for a pure sample. For RNA 
quantification, the 260:280 ratio was 2.0 for a sample with no contamination. 
 
4.8 Template cDNA Synthesis 
 
Complementary DNA (cDNA) template synthesis was then carried using 
Superscript III Reverse Transcriptase (Invitrogen) on each of the eight time point 
EB sample RNAs. The cDNA synthesis reaction used to create template DNA 
was: 
 
RNase-free dH2O 
200ȝJ Random Hexamer Primers  
10 mM dNTP Mix (Invitrogen) 
400ng extracted RNA 
---65϶C for 5 minutes--- 
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5x First Strand Buffer (Invitrogen) 
0.1M DTT (Invitrogen) 
RNaseOut (Invitrogen) 
Superscript III RT (Invitrogen) 
---25϶C for 5 minutes--- 
---50϶C for 60 minutes--- 
---70϶C for 15 minutes--- 
 
To check the integrity of the newly synthesised template cDNA, standard PCR 
was carried using RedTaq ready mix (Sigma) on the PRXVHȕ-Actin housekeeping 
gene. Successful cDNA synthesis was observed by a product band at 302bp after 
electrophoresis on a 1% agarose gel. 
 
4.9 Agarose Gel Electrophoresis 
 
A 1% agarose gel was made up by dissolving 1g of Ultra-Pure agarose 
(Invitrogen) in 100ml of a working stock solution of 1xTAE (Tris-acetate-EDTA) 
DQGKHDWLQJ LQDPLFURZDYH7R WKHGLVVROYHGDJDURVHȝORI(WKLGLXP%URPLGH
(EtBr) was added. An appropriate sized molecular marker ladder was also used 
for molecular size determination. The gel running buffer concentration that used 
was 1x TAE. 
 
For an RNA analysis gel, sample RNA and 6x loading buffer were heated to 75C 
for five minutes and then loaded onto a 1% agarose gel. RNA integrity was 
assessed by two bands representing the two RNA sub-units 28S and 18S; a 
respective 2:1 ratio in band intensity indicated intact RNA.  
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4.10 Gel Extraction 
 
Gel extraction was carried out on DNA samples in a 1% agarose gel. A sharp 
blade was used to excise the band from the gel. The extracted band was then 
subject to purification with a QIAquick Gel Extraction Kit (Qiagen), following the 
WHFKQLFDO PDQXDOV LQVWUXFWLRQV $IWHU H[WUDFWLRQ ȝO RI WKH SXULILHG '1$ VDPSOH
was run on a 1% agarose gel and then visualised for appropriate sized bands. 
 
4.11 Total Protein Extraction 
 
Total protein was extracted from EBs using RIPA buffer. The addition of SDS 
(Sodium Dodecyl Sulphate) and sodium deoxycholate to the RIPA buffer 
increases the denaturing properties. RIPA buffer was chosen for the fact that is 
particularly useful in the extraction of nuclear proteins; a factor attributable to the 
increased denaturing ability. Another advantage of the RIPA buffer when 
conducting Western blots is the fact that a preferable low background reading can 
be obtained. RIPA buffer consists of: 
 
Tris 50mM 
Sodium Chloride (NaCl) 150mM 
Sodium Dodecyl Sulphate (SDS) 0.1% 
Sodium Deoxycholate 0.5% 
Triton X 100 or NP40 1% 
PMSF Protease Inhibitor 
 
EBs ZHUHILUVWZDVKHGZLWK[VWHULOH3%6ȝORI[5,3$EXIIHUZDVDGGHGWR
samples and pipetted up and down repeatedly to lyse cells. Samples were then 
vortexed on full speed for 30 seconds to re-suspend and lyse any remaining cells. 
Samples were then centrifuged on full speed in a cold room for ten minutes to 
pellet and remove cell debris.  
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Supernatant containing total protein was then extracted and transferred to a clean 
and sterile eppendorf tube whilst the cell debris pellet was discarded.  
 
Tissue sample protein extraction was carried out using a pre-sterilised pestle and 
mortar, grinding tissue samples in liquid nitrogen before the addition of 1x RIPA 
buffer. The protease inhibitors in the RIPA buffer stop endogenous protein 
digestion by protease enzymes of mechanical cellular breakdown. Centrifugation 
was carried out to separate the three phases: fat (top layer), desired protein 
(middle), cell debris pellet (bottom). The protein phase was collected and stored at 
-80϶C.  
 
4.12 BIO-RAD Protein Assay for Protein Quantification 
 
The BIO-RAD Protein Assay is a modified Bradford Assay that gives a colorimetric 
measurement of protein concentration in a protein sample. The standard curve 
consisted of 2-ȝJPO %6$ PHDVXUHG DW QP DEVRUEDQFH RQ D
spectrophotometer. To measure the conFHQWUDWLRQRIWKHVDPSOHVȝORIG+2
ZDV PL[HG ZLWK ȝO RI H[WUDFWHG SURWHLQ VDPSOH LQ DQ HSSHQGRUI WXEH ȝO RI
BIO-RAD dye was added and mixed by inversion. The samples were measured 
against the standard curve to obtain a reading of the protein conFHQWUDWLRQȝJȝO 
 
4.13 Western blot 
 
An 8% Polyacrylamide gel was used to analyse protein from extracted EB time 
point samples.  The 8% polyacrylamide gel and 5% stacking gel were made 
according to Maniatis Laboratory Manual Second Edition (Maniatis. T et al., 1989).  
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For 5ml 8% Polyacrylamide Gel: 
 
Distilled water: 2.3ml 
30% acrylamide mix: 1.3ml 
1.5M Tris (pH 8.8): 1.3ml 
10% SDS: 0.05ml 
10% ammonium persulphate: 0.05ml 
TEMED (Fisher Scientific) 0.006ml 
 
For 2ml Stacking/Resolving Gel: 
 
Distilled water: 1.4ml 
30% acrylamide mix: 0.33ml 
1.5M Tris (pH 6.8): 0.25ml 
10% SDS: 0.02ml 
10% ammonium persulphate: 0.02ml 
TEMED (Fisher Scientific) 0.004ml 
 
BIO-RAD gel casts, gel clamps and running docks were used to construct the gel. 
After gel polymerisation, gel wells were washed with sterile, distilled water to 
remove excess acrylamide, before being transferred to a gel dock filled with 1x 
running buffer (30 g of Tris base; 144.0 g of glycine; 10 g of SDS). After protein 
TXDQWLILFDWLRQ SUHSDUDWLRQ RI SURWHLQ VDPSOHV ZDV FDUULHG RXW RQ LFH ȝJ RI
3URWHLQZDVEURXJKWWRDYROXPHRIȝOZLWKdistilled ZDWHUDQGPL[HGZLWKȝORI
[ ORDGLQJG\HȝORIVWRFN[ ORDGLQJG\H6'60JO\FLQHP0
Tris-HVL S+ZDVPL[HGZLWKȝO0'77WRPDNHDZRUNLQJ[ORDGLQJG\H
solution. The protein and loading dye was then boiled for 10 minutes at 95϶C, and 
then centrifuged to collect evaporated sampleȝORIVDPSOHZDVDSSOLHGWRWKH
gel which was run at 100V for one hour.  
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Immunoblot PVDF membrane (BIO-RAD) was soaked in methanol for one minute 
then transferred to 1x transfer buffer (25% methanol; 24mM Tris-HCl; 153mM 
glycine) for ten minutes. The polyacrylamide gel was also soaked in 1x transfer 
buffer along with two sheets of blot paper (BIO-RAD). Components were then 
assembled as follows: blot paper, PVDF membrane, polyacrylamide gel and finally 
another sheet of blot paper.  
 
Semi-dry gel transfer to PVDF membrane was carried out at 300mA for 30 
minutes. Following transfer, the PVDF membrane was blocked by incubating it at 
4϶C overnight in 5% dehydrated low fat milk in 1x PBS (27nm Potassium Chloride, 
14.7mM Potassium Phosphate monobasic, 1.38M Sodium Chloride, 80.6mM 
Sodium Phosphate dibasic (Invitrogenn)) and 0.1% Tween-20. The PVDF 
membrane was then washed for three 10 minute cycles in 1x PBS and 0.1% 
Tween-20.  
 
Primary antibody incubation was carried out overnight at 4϶C in an appropriate 
dilution of antibody 5% low fat milk in 1x PBS and 0.1% Tween-20 in a sealed 
bag. The PVDF membrane was then washed for four 10 minute cycles in 1x PBS 
and 0.1% Tween-20. Secondary Horseradish Peroxidise (HRP) linked antibody 
incubation of the PVDF membrane was then carried out for two hours on a gentle 
agitation rocker. The PVDF membrane was then washed for five 10 minute cycles 
in 1x PBS and 0.1% Tween-20. 
 
Exposure of the PVDF membrane was then carried out by first preparing ECL-
detection reagent (GE Healthcare). This consisted of mixing a 40:1 ration of 
solution A to solution B respectively. ECL-detection solution was then applied onto 
the PVDF membrane and incubated for five minutes under aluminium foil cover to 
prevent light exposure. ECL-detection solution was then drained and the PVDF 
membrane transferred to a dark room.  
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Under red light, chemiluminescence film (GE Healthcare) was placed over the 
PVDF membrane and left to expose for an appropriate length of time.  
 
Exposed chemiluminescence film was then processed automatically using an 
SRX-201 Xograph. Protein transferred PVDF membranes were stored in 1x PBS 
and 0.1% Tween-20 at 4϶C. Stripping of probed PVDF membranes was carried 
out using 1x glycine stripping buffer (0.2M Glycine, 0.05% Tween-20, pH 2.5) for 
one hour at 60϶C in a sealed plastic bag.  
 
4.14 HEK 293T Cell Virus Production 
 
Day 1: 
Lentivirus production was carried out using the HEK 293T cell line. The HEK 293T 
cells were plated on 10cm petri dishes (Sterilin) at a density of 8x10^6 six hours 
before transfection. Plating six hours before transfection was done to allow the 
HEK 293T cells to attach to the petri dish surface and distribute evenly.  
 
Five hundred microlitres of serum-free DMEM/F12 (no serum/antibiotic) was 
SLSHWWHGLQWRDPOHSSHQGRUIWXEHDQGDGGȝO)X*HQHWUDQVIHFWLRQUHDJHQW
(Roche), taking care to avoid the FuGene6 coming into contact with the plastic 
sides of the tube. The transfection mixture was incubated at room temperature for 
5 minutes flicking the tube to mix the transfection mixture. The appropriate 
concentrations of plasmid DNA were then added at the concentrations: 
 
%DFNERQH9HFWRU'1$ȝJ 
SV3$;SDFNDJLQJ'1$ȝJ 
pMD2-*HQYHORSH'1$ȝJ 
 
 
   
30 
 
Incubate the transfection mixture with added plasmid DNA for fifteen minutes and 
mix by flicking to allow the FuGene6 and plasmid DNA to form a complex.  
Finally, add the transfection mixture to 6ml of HEK 293T cell media and add to 
pre-plated HEK 293T cells overnight.  
 
Day 2: 
Change the media on each plate of HEK 293T cells from transfection media to 7ml 
of KSR-replacement mES media.  
 
Day 3: 
Passage a confluent wild-type mES T25 flasks in a 1:6 split from a onto three 
0.1% gelatinised six well plates; one plate per transfected construct. 
 
4.15 Lentiviral Transduction of mES cells 
 
Day 4: 
Collect the virus media from the HEK 293T cells (7ml from each 10cm dish) and 
ILOWHU ZLWK D  PLFURQ ILOWHU 7R WKH PO RI FROOHFWHG YLUXV PHGLD DGG ȝJPO
Polybrene. Add 1ml of virus media to each well of the 0.1% gelatinised six well 
plates containing mES cells plated previously. 
 
Day 5: 
After transduction of the mES cells overnight, replace with freshly collected virus 
media and leave for a second round of transduction.  
 
Day 6: 
Remove the second batch of virus media and replace with fresh KSR-replacement 
mES media prior to passaging the six well plates and scaling up to 0.1% 
gelatinised flasks to maintain stable cultured of transduced cells.  
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4.16 Embryoid Bodies 
 
EBs ZHUHFUHDWHGXVLQJWKH³KDQJLQJGURS´WHFKQLTXHZKLFKUHOLHVRQWKHIRUFHRI
gravity to create a ball of ES cells at the base of a hanging drop. To create the 
EBs, an 80% confluent T25 flask of mES cells was passaged with 0.25% Trypsin 
and then a cell count carried out to determine the volume of cell suspension was 
QHHGHGWRFUHDWHDGHILQHGQXPEHURI(%VFRQVLVWLQJRIP(6FHOOVSHUȝO
hanging drop. A multi-channel pipette was used to create approximately fifty 
equally spaced hanging drops on the lid of a 10cm petri dish. PBS was poured 
into the base of the petri dish to prevent the hanging drops from drying out while in 
the incubator at 37϶c at 5% CO2.  
 
The hanging drops were left to form for three days until non-necrotic balls of mES 
cells could be seen in a stereomicroscope. EBs were then collected with a P200 
Gilson pipette by looking down a stereomicroscope. After collection, EBs were 
cultured in EB media, in non-treated and non-attachment 60mm polystyrene 
dishes with the culture media changed every three days. Time point sample EBs 
were then washed twice with sterile cold 1x PBS and stored at -80϶͘ 
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CHAPTER 5: CELL LINES AND CULTURING 
TECHNIQUES 
 
5.1 CGR8 Wild Type mES Cell Line and Culture Media 
 
The wild-type mES cell line that was used in this research was CGR8 (ECACC 
07032901). The mouse CGR8 ES Cell line is characterised by the fact that it is 
feeder-free, i.e. it does not require fibroblast feeder cells to survive. The mES cells 
will be grown and cultured on 0.1% gelatinised flasks with media containing the 
addition of the cytokine leukaemia inhibitory factor (LIF) at 100ng/ml (Chemicon).  
 
A high density of mES cells was maintained (1:3/1:4 dilution on passaging) when 
the cells are grown to optimise the cell cultures and to better mimic the in vivo 
cellular environment. The cells were checked daily for correct morphology to 
assay whether any differentiation had taken place. Mouse ES cells may take on 
neuronal-like morphology if differentiation has taken place. Cell positioning was 
also checked, as normal mES cells cluster and aggregate whereas unhealthy ES 
cells appear isolated. 
 
Mouse ES cells need fresh medium every day after a 1:3 dilution and every other 
day after 1:4 dilution. This is to stop nutrient depletion and acidification. A low 
passage number of cells will be used for this study as genetic malformations 
accumulate with increasing passage and cell age, causing a loss in cell line 
quality. A common characteristic is the accumulation of an extra chromosome 12; 
the chromosome that the Nanog gene is located on. This would affect the results 
that were produced, meaning that a low passage cell culture is desired.    
 
A freeze medium containing 80% DMEM/F12; 10% DMSO and 10% FCS is used 
when storing the mES cell lines.  
   
33 
 
CGR8 mES Media: 
 
DMEM/F12 (Gibco) 
15% Fetal Calf Serum (Sigma) 
2mM Glutamine (Sigma) 
1% Penicillin/Streptomycin (Sigma) 
0.1mM Non-Essential Amino Acids (Sigma) 
0.1mM (x1000) ȕ-Mercaptomethanol (BME) (Sigma) 
Leukaemia Inhibitory Factor 100ng/ml (Chemicon) 
 
5.2 Embryoid Body Culturing Media 
 
Embryoid Body Differentiation Media: 
 
DMEM/F12 (Gibco) 
15% KSR-Replacement (Gibco) 
2mM Glutamine (Sigma) 
1% Penicillin/Streptomycin (Sigma) 
0.1mM Non-Essential Amino Acids (Sigma) 
 
5.3 HEK 293T Cells and Culturing Media 
 
The HEK 293T cells are stored in liquid nitrogen and then thawed to be grown in a 
T25 flask. At a 1:10 dilution, the T25 flasks will need passaging approximately 
every three days but the medium changed every day. Media changed consists of 
aspirating used medium and replacing with 15ml fresh HEK 293T culture medium.  
A freeze medium containing 80% DMEM/F12; 10% DMSO and 10% FCS is used 
when storing the HEK 293T cells. 
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HEK 293T Cell Media: 
 
DMEM/F12 (Gibco) 
10% Fetal Calf Serum (Sigma) 
2mM Glutamine (Sigma) 
1% Penicillin/Streptomycin (Sigma) 
0.1mM Non-Essential Amino Acids (Sigma)  
 
5.4 Transduced mES Cell Line and Culturing Media 
 
Transduced mES cells were produced by the lentiviral transduction of wild type 
CGR8 cells. Like the wild-type CGR8 cell line, the transduced mES cells were 
grown and cultured on 0.1% coated gelatin flasks in the presence of KSR-
replacement media supplemented with leukaemia inhibitory factor (LIF). A high 
density culture was maintained (1:3/1:4 dilution on passaging). 
 
KSR-Replacement ES Cell Media: 
 
DMEM/F12 (Gibco) 
15% KSR-Replacement (Gibco) 
2mM Glutamine (Sigma) 
1% Penicillin/Streptomycin (Sigma) 
0.1mM Non-Essential Amino Acids (Sigma) 
P0[ȕ-Mercaptomethanol (BME) 
Leukaemia Inhibitory Factor 100ng/ml (Chemicon) 
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pSIN Transduced KSR-Replacement ES Cell Media: 
 
DMEM/F12 (Gibco) 
15% KSR-Replacement (Gibco) 
2mM Glutamine (Sigma) 
1% Penicillin/Streptomycin (Sigma) 
0.1mM Non-Essential Amino Acids (Sigma) 
P0[ȕ-Mercaptomethanol (BME) 
Leukaemia Inhibitory Factor 100ng/ml (Chemicon) 
ȝJPO3XURP\FLQ 
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CHAPTER 6: TESTING CONSERVATION OF 
ANCIENT NANOG IN PGC SPECIFICATION 
 
7R DGGUHVV WKH TXHVWLRQ ³,V WKH DELOLW\ RI Nanog over-expression to increase PGC 
induction conserved in ancient NanogV´ ancient Nanog over-expression cell lines 
were utilised. Previous work has shown that mouse Nanog over-expression in EBs 
increases the expression of PGC markers when analysed through RT-PCR (James 
Dixon and Andrew Johnson, unpublished). The aim of the study was to produce EBs 
via hanging drops from mES cell lines over-expressing Nanog ortholog from lower 
chordates and then compare gene expression levels to those seen in EBs produced 
from mES cells transduced with a control vector. The derivation of PGCs from EB 
intermediates has been achieved in various previous studies (Hubner et al., 2003), 
(Nayernia. K et al., 2006).   
 
Mouse ES cell lines containing lower chordate Nanog over-expression trans-genes 
were obtained from Dr James Dixon and Dr Andrew Johnson. The ancient Nanog 
orthologs were isolated by firstly using the axolotl Nanog protein sequence for 
alignment with EST databases to isolate putative orthologs from lower chordate 
species. Their identity as true Nanog orthologs was confirmed elsewhere (Johnson 
and Dixon, unpublished).   
 
6.1 pSIN-EF2-Nanog-Puromycin Over-Expression Vector 
 
The ancient Nanog over-expression lines were created by Dr James Dixon (Institute of 
Genetics, University of Nottingham) by lentiviral transduction of wild type CGR8 mES 
cells with the pSIN-EF2-Nanog-Puromycin vector (Addgene plasmid #16578). Using 
the lentivirus pSIN vector allows for efficient, stable gene delivery and also expression 
in desired mES Cell lines, driven by the constitutive EF1-ĮSURPRWHU 
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The ancient Nanog cDNA orthologs that were sub-cloned into the pSIN-vector and 
subsequently over-expressed in transduced mES cell lines. The ancient Nanogs used 
in this experiment were:  
 
1. pSIN-Axolotl (Ambystoma mexicanum)  
2. pSIN-Mouse (Mus musculus)  
3. pSIN-Sturgeon (Acipenser oxyrhynchus)  
4. pSIN-Acorn Worm (Saccoglossus kowalevskii) 
5. pSIN-Amphioxus V1  (Branchiostoma floridae Vent-1) 
6. pSIN-Amphioxus V2 (Branchiostoma floridae Vent-2) 
 
A control cell line was used to which gene expression and PGC induction could be 
compared. The control cell line was made by transducing mES cells with a pSIN- EF2-
Puromycin vector lacking an insert (pSIN-Empty). Using this line as a control, any 
effect of lentiviral transduction and puromycin selection could be standardised.  
 
pSIN-EF2-Nanog-Puro Plasmid Map: 
 
 
 
 
 
 
 
 
 
 
Figure 8: pSIN-EF2-Nanog-Puromycin construct. The pSIN construct (Addgene 
plasmid #16578) used in the Nanog over-expression experiments (Plasmid Map adapted from 
Addgene) 
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6.2 Ancient Nanog Nanodrop Quantification 
 
After pSIN plasmids were transformed into competent E. Coli 5-Į cells (NEB) and 
amplified, plasmid DNA was isolated from bacterial solutions by using a DNA isolation 
protocol (for full procedure see methods). Below is a table of the measurements 
obtained from the Nanodrop quantification of all six ancient Nanogs. 
 
Cell Line QJȝO 260:280 
pSIN-Axolotl 152.30 1.87 
pSIN-Mouse 158.90 1.86 
pSIN-Sturgeon 217.80 1.88 
pSIN-Acorn Worm 115.70 1.90 
pSIN-Amphioxus V1 90.00 1.82 
pSIN-Amphioxus V2 87.40 1.81 
 
Table 1: Ancient Nanog plasmid DNA quantification. Nanodrop quantification of the 
plasmid DNA of the six ancient Nanog over-expression vectors. The optimised purity ratio for 
DNA at 260:280 is 1.8; the readings obtained fall very close to this figure indicating that there is 
no or very little contamination of the ancient Nanog samples.  
 
 
 
 
Figure 9: Ancient Nanog Gel Electrophoresis. 1% agarose gel electrophoresis of 
ancient Nanog plasmid DNA after Miniprep isolation (Qiagen). 1ȝORI'1$ZDVORDGHGLQWRHDFK
well. Confirmation was bands at appropriate size of approximately 8496bp. 1: pSIN-Empty, 
Lane 2: pSIN-Axolotl, Lane 3: pSIN-Mouse, Lane 4: pSIN-Sturgeon, Lane 5: pSIN-Acorn Worm, 
Lane 6: pSIN-Amphioxus V1, Lane 7: pSIN-Amphioxus V2 
 
Plasmid DNA was isolated for all of the six ancient Nanog over-expression vectors; 
positive conformation was by product bands at the appropriate molecular size of 
8469bp on a 1% agarose gel, corresponding to the size of the pSIN vector and Nanog 
trans-gene insert.   
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The packaging plasmid, psPAX2 (Addgene plasmid #12260), along with the envelope 
plasmid, pMD2-G (Addgene plasmid #12259) are needed for functional lentiviral 
production in conjunction with the pSIN backbone vector.  
 
 
psPAX2 Packaging Plasmid Map         pMD2-G Envelope Plasmid Map 
 
 
 
 
 
 
 
 
 
 
Figure 10 (left) and Figure 11 (right): Packaging and Envelope plasmids. psPAX2 
packaging plasmid) and pMD2-G envelope plasmid were used for functional lentiviral production 
with the appropriate backbone vector in HEK 293T cells (Plasmid Maps adapted from Addgene) 
 
 
 
 
6.3 Embryoid Body Time Point Collection 
 
The transduced ancient Nanog over-expression mES lines were first puromycin 
selected to produce pure cell lines. Pure ancient Nanog mES lines were then used to 
PDNH (%V WKURXJK WKH KDQJLQJ GURS PHWKRG DW RQH WKRXVDQG P(6 FHOOV SHU ȝO
drop. Non-necrotic EBs were then isolated from hanging drops three days after 
formation (day 0), and plated in 60mm non-treated plates (sterilin). A differentiation 
media consisting of mES media without the addition of the cytokine LIF causes 
spontaneous EB differentiation. Differentiation was carried out for a period of ten days, 
changing the EB media every third day. EB time point samples were taken on days 5 
and 10 after formation. These intervals were chosen as an early time point, before 
PGCs are specified, and a late time point, at which any increase in PGC specific 
markers could be quantified.  
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Figure 12: Control and Ancient Nanog over-expression Embryoid Bodies at day 
0. (PEU\RLG%RGLHVFUHDWHGIURPP(6FHOOVSHUȝOKDQJLQJGURSVFROOHFWHGDWGD\DQG
cultured in EB media (no LIF). A: CRG8 wild type; B: pSIN-Empty, C: pSIN-Axolotl; D: pSIN-
Mouse; E: pSIN-Sturgeon; F: pSIN-Acorn Worm, G: Amphioxus V1; H: pSIN-Amphioxus V2 
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Figure 13: Control and Ancient Nanog over-expression Embryoid Bodies at day 
5.  (PEU\RLG%RGLHVFUHDWHGIURPP(6FHOOVSHUȝO hanging drops collected at day 5 
and cultured in EB media (no LIF). A: CRG8 wild type; B: pSIN-Empty, C: pSIN-Axolotl; D: 
pSIN-Mouse; E: pSIN-Sturgeon; F: pSIN-Acorn Worm, G: Amphioxus V1; H: pSIN-Amphioxus 
V2 
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Figure 14: Control and Ancient Nanog over-expression Embryoid Bodies at day 
10. (PEU\RLG%RGLHVFUHDWHGIURPP(6FHOOVSHUȝOKDQJLQJGURSVFROOHFWHGDWGD\
and cultured in EB media (no LIF). A: CRG8 wild type; B: pSIN-Empty, C: pSIN-Axolotl; D: 
pSIN-Mouse; E: pSIN-Sturgeon; F: pSIN-Acorn Worm, G: Amphioxus V1; H: pSIN-Amphioxus 
V2 
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6.4 RNA Extraction and cDNA Synthesis from EB Time Points 
 
RNA was extracted from EB time point samples by firstly using a QIAshredder 
(Qiagen) and then an RNeasy RNA Extraction Kit (Qiagen). Briefly, EBs were washed 
with sterile 1xPBS, lysed, homogenised using the QIAshredder (Qiagen) and then 
passed through the RNA isolation column to trap the RNA in a silica membrane. 
DNase treatment was then carried out on the RNA isolation column using DNaseI 
(Ambion), to remove any remaining double stranded DNA contamination. RNA was 
then denatured and subsequently run on a 1% agarose gel to check the integrity, 
indicated by two distinct bands representing 28S and 18S ribosomal RNA at a 2:1 
intensity ratio respectively. Isolated RNA was then stored at -80°C.  
 
Cell Line QJȝO 260:230 
pSIN-Empty 119.50 2.00 
pSIN-Axolotl 114.6 2.01 
pSIN-Mouse 99.00 2.02 
pSIN-Sturgeon 123.70 2.04 
pSIN-Acorn Worm 88.60 1.92 
pSIN-Amphioxus V1 111.70 2.06 
pSIN-Amphioxus V2 104.40 2.06 
 
Table 2: Embryoid Body RNA quantification at day 5. After RNA was extracted from 
EBs at day 5, RNA, was quantified and checked for purity using a Nanodrop  
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Cell Line QJȝO 260:230 
pSIN-Empty 104.70 1.96 
pSIN-Axolotl 125.20 1.96 
pSIN-Mouse 93.40 1.93 
pSIN-Sturgeon 112.10 1.95 
pSIN-Acorn Worm 88.60 1.92 
pSIN-Amphioxus V1 90.20 1.92 
pSIN-Amphioxus V2 63.20 1.94 
 
 
Table 3: Embryoid Body RNA quantification at day 10. After RNA was extracted from 
EBs at day 10, RNA, was quantified and checked for purity using a Nanodrop  
 
After RNA was extracted, cDNA synthesis was then carried out on 400ng of RNA 
using Superscript III Reverse Transcriptase (Invitrogen). The integrity of the 
V\QWKHVLVHG F'1$ ZDV FKHFNHG E\ 3&5 DPSOLILFDWLRQ XVLQJ PRXVH ȕ-Actin primers 
with a positive and negative (no-RT) control. Successful cDNA synthesis was 
observed by a product band at 302bp after electrophoresis on a 1% agarose gel.  
 
 
 
 
Figure 15: 1% agarose gel electrophoresis to check cDNA integrity. PCR 
DPSOLILFDWLRQZDVFDUULHGRXWZLWKPRXVHȕ-Actin SULPHUVȝORIF'1$V\QWKHVLVHGIURPWKH
RNA extracted from ancient Nanog over-expression EBs was loaded into each well and the 
appropriate band at 302bp visualised. Lane 1: pSIN-Empty, Lane 2: pSIN-Axolotl, Lane 3: pSIN-
Mouse, Lane 4: pSIN-Sturgeon, Lane 5: pSIN-Acorn Worm, Lane 6: pSIN-Amphioxus V1, Lane 
7: pSIN-Amphioxus V2, Lane 8: negative control (no-RT), Lane 9: positive control 
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6.5 RT-PCR Analysis of EB Time Point Samples 
 
RT-PCR was carried out on the ancient Nanog over-expression cDNA for the 
pluripotency associated gene markers Nanog and Oct-4. The early PGC associated 
marker Dazl was assayed along with Vasa, a marker of mature migratory PGCs. A 
PRXVHȕ-Actin housekeeping control was used to normalise levels of gene expression. 
Gene expression assay kits consisting of primer and probe mixes were obtained from 
Applied Biosystems and RT-3&5 FDUULHG RXW DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V
instructions. Accession number for the Applied Biosystems primer and probe kits can 
be seen below: 
 
Nanog, Mm02384862_g1 
Oct-4, Mm00658129_gH 
Actin, Mm02619580_g1 
Dazl, Mm00515630_m1  
Vasa, Mm00802445_m1 
 
The Applied Biosystems TaqMan Gene Expression 7500 system was used to quantify 
levels of endogenous marker gene expression. To compare levels of gene expression, 
PRXVH ȕ-Actin expression from the pSIN-Empty control cell line was used. Relative 
changes in gene expression, (RQ), were calculated for each individual gene marker 
UHODWLYH WR ȕ-Actin &RQVHTXHQWO\ ȕ-Actin expression from the pSIN-Empty cell line 
was assigned an RQ value of 1.0. To analyse the RT-PCR data, Ct (cycle threshold) 
values of the genes of interest were compared to a normalised control gene in EB time 
point samples.  
 
The threshold level was set to intersect a point at which the RT-PCR amplification is in 
the exponential phase. The amplification for each particular gene marker was 
analysed in triplicate, to obtain a mean Ct value.  
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If there was a clear outlying amplification value for a particular triplicate, the 
anomalous result was omitted and consequently a duplicate analysis was carried out.  
 
The comparative Ct approach, or 2 , was used to compare Ct values for each 
gene marker (Bookout and Mangelsdorf, 2003). The Ct value of the gene of interest 
was normalised to the Ct value of the control reference, that is, ȕ-Actin expression 
from the pSIN-Empty control cell line. This produced a quantitative value for the fold 
FKDQJHLQUHODWLYHJHQHH[SUHVVLRQRU¨&W 
 
¨&W &WVDPSOH± Ct (reference) 
¨¨&W ¨&WVDPSOH- ¨&WUHIHUHQFH 
 
Positive and negative error bars for the relative gene expression (RQ) values were 
calculated from the standard deviation of the relative gene expression. 
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Figure 16A: Nanog gene expression at day 5. Nanog relative gene expression analysis 
(y axis) from EB time point samples at day 5 early time point. Relative gene expression was 
calculated using the 2  method. All expression levels are normalised to mouse ȕ-Actin 
from the pSIN-Empty control cell line at day 5. The individual cell lines are indicated on the x-
axis. Error bars were calculated from the standard deviation of the relative gene expression 
 
 
Cell Line RQ Value RQ Standard Deviation 
pSIN-Empty 1.00 0.504 
pSIN-Axolotl 0.52 0.620 
pSIN-Mouse 1.20 0.474 
pSIN-Sturgeon 1.00 0.470 
pSIN-Acorn Worm 0.46 0.196 
pSIN-Amphioxus V1 0.48 0.230 
pSIN-Amphioxus V2 0.80 0.368 
 
 
Figure 16B: Nanog gene expression values and standard deviation RQ at day 5. 
Data table of relative Nanog gene expression at day 5, showing relative gene expression (RQ) 
normalised to mouse ȕ-Actin gene expression in the pSIN-Empty control at day 5 
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Figure 17A: Oct-4 gene expression at day 5. Oct-4 relative gene expression analysis (y 
axis) from EB time point samples at day 5 early time point. Relative gene expression was 
calculated using the 2  method. All expression levels are normalised to mouse ȕ-Actin 
from the pSIN-Empty control cell line at day 5. The individual cell lines are indicated on the x-
axis. Error bars were calculated from the standard deviation of the relative gene expression 
 
 
 
Cell Line RQ Value RQ Standard Deviation 
pSIN-Empty 1.00 0.228 
pSIN-Axolotl 0.27 0.0609 
pSIN-Mouse 0.075 0.0268 
pSIN-Sturgeon 0.32 0.0827 
pSIN-Acorn Worm 0.16 0.0290 
pSIN-Amphioxus V1 0.11 0.0091 
pSIN-Amphioxus V2 0.28 0.0827 
 
 
Figure 17B:  Oct-4 gene expression values and standard deviation RQ at day 5. 
Data table of relative Oct-4 gene expression at day 5, showing relative gene expression (RQ) 
normalised to mouse ȕ-Actin gene expression in the pSIN-Empty control at day 5 
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Figure 18B: Dazl gene expression values and standard deviation RQ at day 5. 
Data table of relative Dazl gene expression at day 5, showing relative gene expression (RQ) 
normalised to mouse ȕ-Actin gene expression in the pSIN-Empty control at day 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18A: Dazl gene expression at day 5. Dazl relative gene expression analysis (y 
axis) from EB time point samples at day 5 early time point. Relative gene expression was 
calculated using the 2  method. All expression levels are normalised to mouse ȕ-Actin 
from the pSIN-Empty control cell line at day 5. The individual cell lines are indicated on the x-
axis. Error bars were calculated from the standard deviation of the relative gene expression 
 
Cell Line RQ Value RQ Standard Deviation 
pSIN-Empty 1.00 0.166 
pSIN-Axolotl 0.38 0.095 
pSIN-Mouse 0.12 0.023 
pSIN-Sturgeon 0.58 0.085 
pSIN-Acorn Worm 0.59 0.074 
pSIN-Amphioxus V1 0.45 0.036 
pSIN-Amphioxus V2 0.34 0.047 
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From the RT-PCR data generated, it can be seen that Nanog expression at day 5 was 
slightly higher in the EBs produced from the pSIN-Mouse Nanog over-expression cell 
line, with an RQ value of 1.20 (RQ SD +/- 0.474) relative to the control. Gene 
expression levels of pSIN-Sturgeon EBs showed very similar levels of Nanog gene 
expression with an RQ value of 1.00 (RQ SD +/- 0.470). Nanog was seen to have 
reduced levels of expression in the Amphioxus V2 produced EBs with an RQ value 
calculated at 0.80 (RQ SD +/- 0.368). Levels of Nanog expression were found to be at 
a lower level but fairly consistent in the other EBs collected at day 5 produced from 
pSIN-Axolotl, pSIN-Amphioxus V1 and  pSIN-Acorn Worm, with a normalised RQ 
values of 0.52 (SD +/- 0.620), 0.48 (RQ SD +/- 0.230) and 0.46 (RQ SD +/- 0.196). In 
all cases Nanog levels in the test cell lines was within two fold of those in controls. 
 
Oct-4 gene expression levels were found to be highest in the control EBs, RQ 1.00 
(RQ SD +/-0.228). Reduced levels of Oct-4 expression were found in the pSIN-
Sturgeon, pSIN-Amphioxus V2 and pSIN-Axolotl produced EBs, with respective RQ 
values calculated at 0.32 (RQ SD+/- 0.0827), 0.28 (RQ SD +/- 0.0623) and 0.27 (RQ 
SD +/- 0.0609). The pSIN-Acorn Worm EBs exhibited relative expression levels of 
0.16 RQ (RQ SD +/- 0.0290). The lowest levels of Oct-4 gene expression was seen in 
the pSIN-Amphioxus V1 and pSIN-Mouse produced EBs, with relative RQ values of 
0.11 (RQ SD +/- 0.0091) and 0.075 (RQ SD +/- 0.0268) respectively.  
 
Analysis of EBs collected at the early time point, showed that the levels of Dazl gene 
expression were highest in the control EBs, with an RQ value at 1.00 (RQ SD +/- 
0.166). Values obtained for pSIN-Acorn Worm and pSIN-Sturgeon display similar 
levels of normalised Dazl gene expression at a RQ value of 0.59 (RQ SD +/-0.074) 
and 0.58 (RQ SD +/- 0.085) respectively. Relative expression levels were found to be 
similar in EBs collected for pSIN-Amphioxus V1, pSIN-Axolotl, and pSIN-Amphioxus 
V2 with RQ values of 0.45 (RQ SD +/- 0.036), 0.38 (RQ SD +/- 0.095) and 0.34 (RQ 
SD +/- 0.047). The lowest levels of expression were seen in EBs formed from the 
pSIN-Mouse Nanog over-expression cell line with a normalised Dazl expression level 
of 0.12 (RQ SD +/- 0.023). 
   
51 
 
 
 
 
 
 
 
 
 
 
 
Figure 19A: Nanog gene expression at day 10. Nanog relative gene expression 
analysis (y axis) from EB time point samples at day 10 early time point. Relative Gene 
Expression was calculated using the 2  method. All expression levels are normalised to 
mouse ȕ-Actin from the pSIN-Empty control cell line at day 10. The individual cell lines are 
indicated on the x-axis. Error bars were calculated from the standard deviation of the relative 
gene expression 
 
Cell Line RQ Value RQ Standard Deviation 
pSIN-Empty 1.00 0.148 
pSIN-Axolotl 2.72 0.598 
pSIN-Mouse 8.33 0.591 
pSIN-Sturgeon 3.22 0.126 
pSIN-Acorn Worm 3.94 0.567 
pSIN-Amphioxus V1 2.69 0.217 
pSIN-Amphioxus V2 6.76 0.762 
 
Figure 19B: Nanog gene expression values and standard deviation RQ at day 
10.  Data table of relative Nanog gene expression at day 10, showing relative gene expression 
(RQ) normalised to mouse ȕ-Actin gene expression in the pSIN-Empty control at day 10 
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Figure 20A:  Oct-4 gene expression at day 10. Oct-4 relative gene expression analysis 
(y axis) from EB time point samples at day 5 early time point. Relative gene expression was 
calculated using the 2  method. All expression levels are normalised to mouse ȕ-Actin 
from the pSIN-Empty control cell line at day 10. The individual cell lines are indicated on the x-
axis. Error bars were calculated from the standard deviation of the relative gene expression 
 
 
Cell Line RQ Value RQ Standard Deviation 
pSIN-Empty 1.00 0.373 
pSIN-Axolotl 8.06 3.264 
pSIN-Mouse 8.26 3.665 
pSIN-Sturgeon 4.30 1.960 
pSIN-Acorn Worm 6.58 0.923 
pSIN-Amphioxus V1 7.17 0.315 
pSIN-Amphioxus V2 16.20 1.210 
 
Figure 20B: Nanog gene expression values and standard deviation RQ at day 
10.  Data table of relative Oct-4 gene expression at day 10, showing relative gene expression 
(RQ) normalised to mouse ȕ-Actin gene expression in the pSIN-Empty control at day 10 
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Figure 21A: Dazl gene expression at day 10. Dazl relative gene expression analysis (y 
axis) from EB time point samples at day 5 early time point. Relative gene expression was 
calculated using the 2  method. All expression levels are normalised to mouse ȕ-Actin 
from the pSIN-Empty control cell line at day 10. The individual cell lines are indicated on the x-
axis. Error bars were calculated from the standard deviation of the relative gene expression 
 
 
 
Figure 21B:  Dazl gene expression values and standard deviation RQ at day 10.  
Data table of relative Dazl gene expression at day 10, showing relative gene expression, 
QRUPDOLVHGWRPRXVHȕ-Actin gene expression in the pSIN-Empty control at day 10 
 
 
 
Cell Line RQ Value RQ Standard Deviation 
pSIN-Empty 1.00 0.157 
pSIN-Axolotl 4.07 0.613 
pSIN-Mouse 11.38 2.917 
pSIN-Sturgeon 5.29 0.329 
pSIN-Acorn Worm 13.19 3.006 
pSIN-Amphioxus V1 4.81 1.509 
pSIN-Amphioxus V2 20.25 1.529 
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Figure 22A: Vasa gene expression at day 10. Vasa relative gene expression analysis (y 
axis) from EB time point samples at day 5 early time point. Relative Gene Expression was 
calculated using the 2  method. All expression levels are normalised to mouse ȕ-Actin 
from the pSIN-Empty control cell line at day 10. The individual cell lines are indicated on the x-
axis. Error bars were calculated from the standard deviation of the relative gene expression 
 
Cell Line RQ Value RQ Standard Deviation 
pSIN-Empty 1.00 0.126 
pSIN-Axolotl 1.83 0.198 
pSIN-Mouse 3.29 0.169 
pSIN-Sturgeon 1.86 0.349 
pSIN-Acorn Worm 1.88 0.209 
pSIN-Amphioxus V1 1.94 0.103 
pSIN-Amphioxus V2 1.95 0.180 
 
Figure 22B:  Vasa gene expression values and standard deviation RQ at day 10.  
Data table of Relative Vasa gene expression at day 10, showing relative gene expression (RQ), 
normalised to mouse ȕ-Actin gene expression in the pSIN-Empty control at day 10 
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When Nanog gene expression levels were analysed at late stage day 10 time point, 
the normalised pSIN-Empty cell line exhibited the lowest levels of expression with a 
baseline RQ value of 1.00 (RQ SD +/- 0.148). On a whole, the overall trend of the 
normalised Nanog gene expression levels was observed to increase in all of the 
ancient pSIN-Nanog cell lines. The pSIN-Mouse cell line was seen to show the highest 
levels of normalised Nanog gene expression with an RQ value of 8.33 (RQ SD +/- 
0.591). This was then followed by the quantitative pSIN-Amphioxus V2 Nanog gene 
expression level, with a normalised RQ value of 6.76 (RQ SD +/- 0.762). Expression 
levels for EBs produced from pSIN-Acorn Worm, pSIN-Sturgeon, pSIN-Amphioxus V1 
and pSIN-Axolotl were seen to have comparable levels of normalised Nanog gene 
expression with RQ values of 3.94 (RQ SD +/- 0.567), 3.22 (RQ SD +/- 0.126), 2.69 
(RQ SD +/-0.217) and 2.72 (RQ SD +/- 0.598) respectively. 
 
The lowest levels of Oct-4 expression in the EBs collected at the late day 10 time point 
sample were seen to be in the normalised pSIN-Empty control, RQ 1.00 (RQ SD +/- 
0.373). Up-regulation in Oct-4 gene expression in the EBs produced from the cell lines 
pSIN-Axolotl, pSIN-Mouse and pSIN-Sturgeon, with RQ values calculated to be 8.06 
(RQ SD +/- 3.264), 8.26 (RQ SD +/- 3.665 and 4.30 (RQ SD +/- 1.960). Though there 
was an up-regulation in the expression of Oct-4, error bars calculated from the 
standard deviation of RQ for these particular cell lines were found to be large making 
accurate quantification of expression levels difficult. The standard error of the RQ is 
due to the variance of the technical triplicate repeats from the mean Ct value. Relative 
expression values for pSIN-Amphioxus V1 and pSIN-Acorn Worm were seen to be up-
regulated by similar levels, RQ 7.17 (RQ SD +/- 0.315) and 6.58 (RQ SD +/- 0.923) 
respectively. Robust Oct-4 gene expression levels were seen in the pSIN-Amphioxus 
V2 produced EBs. These were by far the highest levels exhibited by the ancient 
Nanog over-expression cell lines, with a relative RQ value calculated at 16.20 (RQ SD 
+/- 1.210). 
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As with the relative levels of Nanog gene expression levels seen at the day 10 time 
point samples, the pSIN-Empty cell line produced EBs exhibited the lowest levels of 
Dazl expression when analysed through RT-PCR quantification, with an RQ value of 
1.00 (RQ SD +/-0.157). Dazl gene expression levels were seen to be significantly 
increased in the pSIN-Amphioxus V2 ancient Nanog over-expression EBs, when 
compared to the normalised mouse Actin gene expression levels in the pSIN-empty 
control. The pSIN-Amphioxus V2 EBs showed an RQ value of 20.25 (RQ SD +/-
1.529), a robust Dazl gene expression increase. There was also a robust increase in 
Dazl gene expression in both the pSIN-Acorn Worm and pSIN-Mouse produced EBs, 
with an RQ readout values of 13.19 (RQ SD +/-3.001) and 11.38 (SD+/- 2.917) 
respectively. Similar levels of Dazl expression were seen for both the pSIN-Sturgeon, 
pSIN-Amphioxus V1 and pSIN-Axolotl over-expression EBs, with relative RQ values of 
5.29 (RQ SD +/-0.329), 4.81 (RQ SD +/-1.507) and 4.07 (RQ SD +/-0.617) 
respectively.  
 
Levels of Vasa gene expression were found to be up-regulated in all of the ancient 
Nanog over-expression EBs, compared to the normalised mouse ȕ-Actin gene 
expression of the pSIN-Empty cell line, RQ 1.00 (RQ SD +/- 0.126). It was observed 
that the highest levels of Vasa expression was in the pSIN-Mouse produced EBs, with 
a relative RQ value of 3.29 (RQ SD +/- 0.169). Levels of Vasa gene expression levels 
were found to present at comparable levels in the other ancient Nanog over-
expression EBs with RQ values calculated for pSIN-Axolotl, pSIN-Sturgeon, pSIN-
Acorn Worm, pSIN-Amphioxus V1 and pSIN-Amphioxus V2 at 1.83 (RQ SD +/- 
0.198), 1.86 (RQ SD +/- 0.349), 1.88 (RQ SD +/- 0.209), 1.94 (RQ SD +/- 0.103) and 
1.95(RQ SD +/- 0.180) respectively.  
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.6.6 Protein Extraction and Western blot Analysis  
 
I extracted total protein from EBs collected at the final day 10 time point, which was 
used to assess target protein levels. Protein levels were measured by Western blot 
analysis. Total protein was isolated from EB time point samples by using RIPA buffer 
WR O\VH (%V%ULHIO\ ȝORI[ RIPA buffer was then added to each sample to lyse 
cells, followed by vortexing and centrifugation to remove cellular debris. Protein 
samples were then measured using a BIO-RAD protein assay against a negative 
reference in a light spectrophotometer at 595nm.  
 
Cell Line ȝJȝODWQP 
CGR8 W/T 9.00 
pSIN-Empty 6.80 
pSIN-Axolotl 13.90 
pSIN-Mouse 15.10 
pSIN-Sturgeon 12.40 
pSIN-Acorn Worm 13.70 
pSIN-Amphioxus V1 16.20 
pSIN-Amphioxus V2 12.80 
Mouse Testis (+ve) 50.00 
Mouse Spleen (-ve) 22.10 
 
Table 4: Embryoid Body total protein quantification at day 10. BIO-RAD protein 
quantification analysis for EBs collected at the late Day 10 time point. The table includes the 
protein concentration for positive control (mouse testis) as well as negative control (mouse 
spleen). Extracted protein was quantified by the measuring against a standard curve at 595nm 
in a spectrophotometer 
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A Western blot was carried out to analyse the pSIN-mouse Nanog over-expression 
trans-gene. The transgene was tagged with a C-terminal Myc tag, which could be 
utilised to detect Nanog protein levels in EBs formed from transduced mES cells. 20ȝJ 
of sample protein were loaded and ran against a rainbow molecular of known weight 
marker for size determination. Nanog protein is around 34kDa in size.  
 
The Primary Myc-antibodies were obtained from Abcam (Ab #9106) and diluted 
DFFRUGLQJ WR PDQXIDFWXUHU¶V LQVWUXFWLRQV DW  LQ  GHK\GUDWHG ORZ IDW PLON LQ
1xPBS and 0.1% Tween-20. Horseradish Peroxidise (HRP) conjugated anti-rabbit 
VHFRQGDU\DQWLERGLHV&HOO6LJQDOOLQJDQGGLOXWHGDFFRUGLQJWRPDQXIDFWXUHU¶V
instructions at 1:3000 in 5% dehydrated low fat milk in 1x PBS and 0.1% Tween-20.  
 
To compare over-expression levels of the mouse Nanog transgene, wild type CGR8 
and pSIN-Empty control EBs were also probed. If the mouse Nanog transgene is 
functioning correctly, a significantly more intense band should be seen at the 
appropriate size when visualised compared to the control pSIN-Empty and wild type 
CGR8 cell lines, which have no transgene Myc-tag.  
 
Anti-Myc Western blot: 
 
 
 
 
 
Figure 23: Anti-Myc Western blot for Nanog transgene over-expression. Anti-Myc 
Western blot carried out with anti-Myc primary antibodies along with secondary anti-rabbit HRP-
conjugated antibodies exposed for five minutes. Far left: protein isolated from EBs CGR8 wild-
type, middle: protein isolated from pSIN-Empty EBs, Far Right: protein isolated from pSIN-
Mouse over-expression EBs 
 
 
34kDa 
CGR8 pSIN-Empty pSIN-Mouse 
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The Western blot shows that significant Myc expression protein from pSIN-Mouse 
over-expressing EBs. Comparison with protein from control lines confirms over-
expression of the mouse Nanog transgene.  
 
The Vasa homolog MvhI (DDX4) is specifically expressed in germ cells and as a 
result, the mouse Vasa will be used as a marker of later stage PGC specification in EB 
intermediates. Primary anti-MvhI antibodies were obtained from Abcam (Ab #13840) 
and used in conjunction with secondary anti-rabbit antibodies to probe for MvhI in late 
stage (day 10 EB) time point samples. As a positive control to test the anti-MvhI 
antibodies, both mouse and mat ovaries were obtained from sacrificed female CD1 
strain. A negative control consisting of mouse spleen was also used to assess correct 
antibody specificity. Whole tissue sample preparation was carried out before total 
protein was extracted using mechanical grinding combined with RIPA buffer, to 
solubilise proteins. 20ȝJ of sample protein were loaded into each lane.  
 
 
 
 
 
 
 
 
 
Figure 24 (Above): Ancient Nanog Embryoid Body anti-Vasa Western blot. Anti-
Vasa (mouse MvhI) Western blot carried out with anti-Vasa primary antibodies along with 
secondary anti-rabbit HRP-conjugated antibodies to probe protein isolated from late time point 
day 10 EBs (exposed for five minutes). Lane 1: mouse testis (positive control), Lane 2: mouse 
spleen (negative control), Lane 3: pSIN-Empty, Lane 4: pSIN-Axolotl, Lane 5: pSIN-Mouse, 
Lane 6: pSIN-Sturgeon, Lane 7: pSIN-Acorn Worm, Lane 8: pSIN-Amphioxus V1, Lane 9: pSIN-
Amphioxus V2. Figure 25 (Below): MAPK protein loading control. MAPK loading 
control using anti-ERK2 primary antibodies along with secondary anti-rabbit HRP-conjugated 
antibodies. Protein loaded in corresponding lanes  
 
 
 
 
76kDa 
1 2 3 4 5 6 7 8 9 
42kDa 
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The Western blot shows an intense band at the appropriate molecular weight of 
76kDa for mouse Vasa in the positive control (lane 1) and no band visible for the 
negative control (lanes 2 and 3). There can be bands present.  MAPK protein loading 
control was then carried out to confirm equivalent protein loading using primary ERK-2 
antibodies (C-14 Santa CUX] %LRWHFKQRORJLHV GLOXWHG DFFRUGLQJ WR PDQXIDFWXUHU¶V
instructions at 1:2000 in 5% dehydrated low fat milk in 1xPBS and 0.1% Tween-20. 
Secondary anti-rabbit HRP-conjugated antibodies were then used (Cell Signalling 
#7076) and diluted according to manufDFWXUHU¶V LQVWUXFWLRQV DW  LQ 
dehydrated low fat milk in 1xPBS and 0.1% Tween-20. Appropriate bands at 42kDa 
were observed in corresponding lanes.  
 
There was a problem identified whilst carrying out the MAPK loading control on the 
anti-Vasa Western blot, which resulted in the variance seen in the band intensities. 
However, due to time restrictions on the project completion, it was not possible to 
carry out a repeat loading control.  
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CHAPTER 7: DISCUSSION 
 
7.1 Ancient Nanog Over-expression Enhances PGC Specification 
 
Nanog has been shown to play a key role in the regulation of ES cells and the 
pluripotent state (Chambers. I et al., 2003a), (Mitsui. K et al., 2003b), (Silva. J et al., 
2006),(Silva. J et al., 2009), whilst also being expressed and required for germ cell 
maturation (Chambers. I et al., 2007). In regards to the foundation work which gave 
rise to this project, it was reaffirmed in this study that mouse Nanog over-expression 
enhanced the process of PGC specification. This was shown by the increased PGC 
associated gene marker expression, corroborating with work that was carried out by 
James Dixon and Andrew Johnson (unpublished). From the RT-PCR gene expression 
data generated for the ancient Nanog over-expression EB time point samples, there is 
a strong suggestive trend in the data.  
 
In all, gene expression levels in the ancient Nanog over-expression EBs were found to 
display slightly lower levels of expression, however, on a comparable scale with 
expression levels of the pSIN-Empty control population of EBs. Firstly, at the early EB 
collection time point, at day five, gene markers for the pluripotency associated factors 
Nanog and Oct-4 are seen to be at low levels, on a comparable scale to the 
expression levels seen in the control pSIN-Empty produced EBs. The same trend in 
results can be seen for the early PGC associated marker Dazl when assayed through 
quantitative RT-PCR at the early stage day 5 time point. These results lead to the 
conclusion that in the early time point collected EBs, marker gene expression was 
indicative of the fact that PGCs were yet to be specified.  
 
Another possible explanation to the results obtained for the early time point is the fact 
that both Nanog and Oct-4 are both expressed in pluripotent cells, as well as being 
expressed in the germline cells. Remaining pluripotent cells may still be present in the 
differentiating EBs at the early day 5 time point.  
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As the time course of EB differentiation progressed to the day 10 time point, it can be 
clearly seen that target gene expression for both Nanog and Oct-4 assayed by RT-
PCR is up-regulated in all of the ancient Nanog over-expression cell lines. Western 
blot analysis probing for the Myc tag on the C-terminal domain of the Nanog over-
expression transgene confirmed the over-expression in the pSIN-Mouse EBs. It was 
assumed that the other ancient Nanogs were also over-expressed in EBs to the same 
extent; however, it could not be confirmed as they contained no C-terminal Myc tag. 
The use of an anti-Nanog antibody used in Western blot analysis could be used in 
further work to confirm the elevated Nanog levels in the ancient Nanog EBs. Up-
regulated Dazl and Vasa expression relative to the control, suggests PGC induction by 
the 10 day collection point. Most importantly, the process of PGC specification was 
apparently enhanced by ancient Nanog over-expression. Further, at this late stage of 
differentiation pluripotent cells would not be expected to be retained in the EBs. 
Control EBs carrying the pSIN-Empty vector showed the lowest levels of Dazl and 
Vasa gene expression at day 10.  
 
The ancient Nanog genes showed varying abilities to augment, or induce, PGC 
specification. It was shown that the axolotl, sturgeon and amphioxus Nanogs exhibited 
the weakest enhancement of PGC specification. There was between a 2.7 
(Amphioxus V1) and 8.3 (Mouse) fold relative increase in Nanog gene expression 
observed over the control population of EBs.  
 
 In comparison, Oct-4 gene expression was seen to be up-regulated at between 4.3 
(Sturgeon) and 16.2 (Amphioxus V2) fold relative to the control EBs. The same data 
trend was seen for the early PGC specific marker Dazl which showed up-regulation in 
all of the assayed ancient Nanog over-expression lines relative to control levels of 
between 4.04 fold increase (Axolotl) and 20.3 fold increase (Amphioxus V2).  
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Vasa gene expression for the ancient Nanog over-expression lines was also increased 
over the pSIN-Empty control. The pSIN-Mouse produced EBs showed the largest 
increase in Vasa expression, with a relative increase calculated at 3.3. Vasa 
expression levels were up-regulated in the other ancient Nanog over-expression cell 
lines by about two fold over the control. The Western blot data generated by probing 
total protein extracted from the day 10 ancient Nanog EBs for Vasa, showed no visible 
levels in the control population of EBs. As there was low amount of non-specific 
background in the Western blot, computational analysis of relative band intensities 
proved problematic; therefore they were analysed visually. Comparable levels of Vasa 
protein were seen for the pSIN-Axolotl, pSIN-Sturgeon and pSIN-Amphioxus V1 
produced EBs; termed baseline levels for visual analysis. There were increases seen 
in the Vasa protein levels observed in the EBs produced from the pSIN-Mouse and 
pSIN-Acorn Worm cell lines of approximately twofold over base line levels. There was 
however, a significant up-regulation seen in Vasa protein levels detected in the pSIN-
Amphioxus V2 produced EBs. The increase in Vasa protein levels was seen to be at 
approximately a threefold visual increase over the base line levels of Vasa protein 
levels; however, more accurate levels were not able to be quantified because of 
problems with computational analysis. These results reaffirmed the corresponding RT-
PCR data generated Vasa gene expression at the late stage day 10 time point. 
 
As the Applied Biosystems primers used detected endogenous levels of gene 
expression, it is clear that ancient Nanog over-expression in EBs was shown to up-
regulate endogenous gene levels. Further work into looking at solely endogenous 
levels of Nanog gene expression could use TaqMan RT-PCR primers targeted to the 
¶ 875 UHJLRQ PHDQLQJ WKDW RQO\ HQGRJHQRXV OHYHOV RI Nanog would be detected 
through RT-PCR analysis. 
 
The ancient Nanog over-expression cell lines that are of particular interest are those of 
the pSIN-Amphioxus V2 and pSIN-Acorn Worm. In EBs from these cell lines, Nanog, 
Oct-4, Dazl and Vasa gene expression were found to be up-regulated.  
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The high levels of both Nanog and Oct-4 gene expression in ancient Nanog over-
expressing cell lines correlate with the robust increase that was seen in the PGC 
associated gene marker Dazl at the late stage day 10 time point. In the pSIN-
Amphioxus V2 produced EBs, levels of Vasa gene expression were found to be at a 
two fold increase when analysed through quantitative RT-PCR, but were found to be 
at approximately a threefold visual increase over baseline Vasa protein levels when 
analysed through Western blot. In the pSIN-Acorn Worm produced EBs, Nanog, Oct-4 
and Dazl were found to be up-regulated by normalised gene expression levels of 4, 
6.6 and 13.2 respectively. Again, as was seen in the pSIN-Amphioxus V2, high levels 
of Nanog and Oct-4 correlated with a robust increase in the level of the PGC 
associated Dazl gene marker. Levels of Vasa gene expression were found to correlate 
with probed levels of Vasa protein through Western blot analysis, which were found to 
be at a two fold increase over baseline levels.  
 
It is also noteworthy that Amphioxus V1 (Vent-1) over-expression in EBs proved to be 
inefficient in the process of enhancing PGC specification. This is in stark contrast with 
Amphioxus V2 (Vent-2), which was the most efficient in inducing PGCs from EBs. This 
data therefore suggest that Amphioxus Vent-2 has functional similar to Nanog in the 
process of PGC specification, suggesting this function is conserved. Interestingly, 
these data suggest that the basal function of Nanog in chordates is in the specification 
of PGCs, with other related functions evolving over time.  
 
(Dixon. J. E et al., 2010), showed that Nanog genes from axolotl, and other lower 
chordates, are expressed as a monomer, in contrast to the dimers formed by mouse 
Nanog and human NANOG.  My study shows that monomeric forms of Nanog, lacking 
the WR repeat domain, can function to enhance the process of PGC specification. 
This finding complements studies showing that monomeric Nanogs can interact with 
molecules in the mammalian pluripotency network (Dixon. J. E et al., 2010). 
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One possible reason for the low levels of Vasa gene expression and Vasa protein 
levels observed could be the late stage at which Vasa is turned on in normal 
development . Studies by (Fujiwara. Y et al., 1994) have shown that MvhI (mouse 
Vasa), is detectable at 12.5d.p.c. Further work by (Toyookaa. Y et al., 2000) has 
shown through whole mount staining that there are no MvhI-positive cells detectable 
between 7.5-9.5 d.p.c., however between 10.5-11.5d.p.c. MvhI-positive cells were 
detectable in the undifferentiated genital ridges. As the late time point EB collection 
was at day 10, this may have been too early in PGC development.  To test this, EBs 
could be cultured for longer periods, on the order of weeks rather than days. This 
approach could also be relevant to the data for Nanog and Oct-4 expression. As Oct-4 
and Nanog are markers of pluripotent cells, in addition to PGCs, PGC specific 
expression might be more accurately determine at later stages.  It is impossible to be 
certain that the expression we see is a result of enhanced PGC production in the EBs, 
or simply higher expression from resident PGCs. To determine the numbers of PGCs 
produced in EBs would require Immunohistochemistry, using antibodies to PGC 
specific proteins. 
  
An interesting avenue of future work would be to carry out other ancient Nanog over-
expression EB experiments, such as over-expressing the recently characterised sea 
anemone Nanog. The sea anemone is a diploblast, i.e. it contains the ectoderm and 
endoderm germ cell layers but lacks mesoderm. Diploblasts evolved before the 
appearance of triploblastic organisms. Consequently, if enhancement of PGC 
specification, observed in the pSIN-Amphioxus V2 cell line, could be repeated with 
Nanog orthologs from diploblasts, then it would provide more evidence for the idea 
that the ancient function of Nanog was indeed in germ cell specification and 
pluripotency, with more modern functions evolving subsequently.  
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7.2 Biological Replicate of Ancient Nanog Over-Expression  
 
As well as extending the findings of this study, biological repeats of the experiments 
performed are needed to reaffirm the results that were seen. After the completion of 
the first ancient Nanog over-expression experiment, a repeat experiment was carried 
out. It was decided that the time points at which EBs were collected in repeat 
procedures should be changed to better capture the EB differentiation time course. It 
was decided that new EB time point samples were to be collected firstly on Day 0 (EB 
formation day) and then on day 3, day 6 and day 9 and 14 after EB formation. This 
would give a better picture of when PGCs are specified in differentiating EBs and 
allow the gene expression profiles of target genes to be tracked over an extended 
period of time.  
 
However, it was found that insufficient RNA could be collected from many of the time 
point EB samples. Problems were then encountered with quantitative RT-PCR 
analysis. Template cDNA produced from RNA extracted from the ancient Nanog over-
expression EBs could not be amplified. Correct template cDNA production was seen 
WKURXJK WKH XWLOLVDWLRQ RI PRXVH ȕ-Actin primers and standard PCR amplification, 
however no amplification could be obtained for any of the gene markers through RT-
PCR. Due to time constraints on project completion, there was no data available for 
the biological repeat of the ancient Nanog over-expression experiment at the time of 
thesis completion; however, replicate experiments are currently underway.  
 
7.3 Final Conclusion and Summation of Work 
 
In relation to the initial aims set out in this project and the hypothesis on which it is 
based, it has been shown that the over-expression of ancestral Nanog orthologs in 
mES cells can function to enhance the process of PGC specification. This study 
provides evidence for the hypothesis that the functional activity of Nanog is conserved 
through some species of deuterostomes and also that pluripotency is an ancient trait.  
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